Greystone Financial Group, LLC Becton Dickinson & CO Transaction History

Greystone Financial Group, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 01, 2023	BUY	$254.9 - $283.59 $527,388 - $586,747	2,069 Added 6.84%	32,318 $8.36 Million
Q2 2023 Jul 18, 2023	SELL	$238.39 - $265.32 $87,250 - $97,107	-366 Reduced 1.2%	30,249 $7.99 Million
Q1 2023 Apr 25, 2023	BUY	$229.71 - $259.35 $172,741 - $195,031	752 Added 2.52%	30,615 $7.58 Million
Q4 2022 Jan 23, 2023	BUY	$218.29 - $256.91 $29,032 - $34,169	133 Added 0.45%	29,863 $0
Q3 2022 Oct 25, 2022	SELL	$51.03 - $264.23 $15,309 - $79,269	-300 Reduced 1.0%	29,730 $6.63 Million
Q2 2022 Aug 03, 2022	BUY	$234.74 - $275.42 $144,130 - $169,107	614 Added 2.09%	30,030 $7.4 Million
Q1 2022 May 02, 2022	BUY	$243.64 - $270.48 $241,690 - $268,316	992 Added 3.49%	29,416 $7.83 Million
Q4 2021 Feb 01, 2022	BUY	$230.08 - $250.94 $1.63 Million - $1.78 Million	7,076 Added 33.15%	28,424 $7.15 Million
Q3 2021 Nov 03, 2021	SELL	$232.72 - $256.47 $1.41 Million - $1.56 Million	-6,079 Reduced 22.16%	21,348 $5.25 Million
Q2 2021 Aug 13, 2021	BUY	$232.65 - $254.58 $66,770 - $73,064	287 Added 1.06%	27,427 $6.67 Million
Q1 2021 May 13, 2021	BUY	$232.09 - $256.88 $6.3 Million - $6.97 Million	27,140 New	27,140 $6.55 Million

1,799

260M

1.28M

1.12M

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $64.1B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

Get notified when there are updates to the investment portfolio of Greystone Financial Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Greystone Financial Group, LLC with notifications on news.